Sign in and upgrade to a paid plan to export corporate actions as CSV.

Metropolis Healthcare Limited

Healthcare · Healthcare Services

NSE: METROPOLIS BSE: 542650

About Metropolis Healthcare Limited

Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019.

Source: Wikipedia

Key facts

BSE symbol542650
NSE symbolMETROPOLIS
ISININE112L01020
CINL73100MH2000PLC192798
Listing date15 Apr 2019
Fiscal year end31 Mar
SectorHealthcare
IndustryHealthcare Services
AuditorManish Ghia & Associates, Company Secretaries (Mannish L. Ghia)
Registered office4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli
Registrar & transfer agentMUFG Intime India Private Limited C 101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, Maharashtra, India.

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)1,382†1,234†1,115†—993†
Net profit157125116139162†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Ameera ShahExecutive DirectorJune 30, 2026
Surendran ChemmenkotilExecutive DirectorJune 30, 2026
Purvi ShethIndependent DirectorJune 30, 2026
Rehan KhanIndependent DirectorJune 30, 2026
Sanjay BhatnagarIndependent DirectorJune 30, 2026
Subramanian RanganathanIndependent DirectorJune 30, 2026
Vivek GambhirIndependent DirectorJune 30, 2026
Aparna Chetan RajadhyakshaNon-Executive DirectorJune 30, 2026
Hemant SachdevNon-Executive DirectorJune 30, 2026
Sushil Kanubhai ShahNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.